We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
40 hedge funds and large institutions have $60M invested in scPharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
60% more call options, than puts
Call options by funds: $131K | Put options by funds: $82K
51% more capital invested
Capital invested by funds: $39.8M → $60M (+$20.2M)
5% more funds holding
Funds holding: 38 → 40 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.17% less ownership
Funds ownership: 57.34% → 51.18% (-6.2%)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
9
Reduced
15
Closed
2
Calls
$131K
Puts
$82K
Net Calls
+$49K
Net Calls Change
+$49K
Top Buyers
| 1 |
JGC
J. Goldman & Co
New York
|
+$270K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$138K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$121K |
| 4 |
RWM
Ritholtz Wealth Management
New York
|
+$80.1K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$75.8K |
Top Sellers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$3.15M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.16M |
| 3 |
5VM
5AM Venture Management
San Francisco,
California
|
-$1.21M |
| 4 |
AC
Armistice Capital
New York
|
-$1.11M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$788K |
